Biotechnology
Angel Yeast Partners with ffit8 to Launch Nougat Protein Bar and Protein Nougat Snack
SHANGHAI, July 2, 2024 /PRNewswire/ -- Angel Yeast
2024-07-02 20:00
12719
Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease
SHANGHAI, July 2, 2024 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and first two patients enrollment for its global multicenter clinical study...
2024-07-02 19:10
2244
PharmAbcine's Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration Advances to Both Single-dose of 4mg and Multiple-dose of 3mg
* Safety Review Committee (SRC) approves single 3mg dose for the third cohort in Phase 1 trial of PMC-403 DAEJEON, South Korea, July 2, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ:208340), a clinical-stage public company developing next generation therapeutic...
2024-07-02 11:02
2153
HiRO acquires CRO DeltaMed Solutions, continues to expand cross-border operations in the US
WILMINGTON, Del., July 2, 2024 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful acquisition of DeltaMed Solutions, an emerging CRO with a robust foothold in the US. The acquis...
2024-07-02 10:00
3416
Innovent Announces Oral Presentation at the ESMO Gastrointestinal Cancers Congress 2024 on Latest Clinical Data of Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
SAN FRANCISCO and SUZHOU, China, July 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
2024-07-02 08:00
3565
Altos Biologics Files for Approval of Aflibercept Biosimilar
DAEJEON, South Korea, July 1, 2024 /PRNewswire/ -- Alteogen Inc.
2024-07-02 08:00
2794
Bridgewest Perth Pharma gains strategic edge with noted Australian Executive John Van Der Wielen on Board
PERTH, Australia, July 2, 2024 /PRNewswire/ -- Bridgewest Perth Pharma, global pharmaceutical holding company withNovaCina CDMO division and LumaCina pharmaceutical supply division, announces the addition of renown Australian executiveJohn Van Der Wielen to Board of Directors. Van Der Wielen will...
2024-07-02 07:00
2091
HistoIndex Charts New Course in Liver Disease Innovation: Announces Pivotal Changes to Scientific Advisory Board
* Company to appoint Prof. Arun J. Sanyal as the new Chairman of HistoIndex's Scientific Advisory Board, bringing unparalleled expertise to guide future innovations. * Prof. Vlad Ratziu joins the Scientific Advisory Board to strengthen the Company's global scientific leadership in liver disea...
2024-07-01 20:00
2563
IASO Bio Presented Clinical Data and Single-cell Analysis of Equecabtagene Autoleucel for the Treatment of Central Nervous System Autoimmunity in Oral Presentation at EAN Congress 2024
SHANGHAI, NANJING, CHINA, and SAN JOSE, Calif., July 1, 2024 /PRNewswire/ -- IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented the clinical data and single-cell an...
2024-07-01 15:43
1484
SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors
SINGAPORE, July 1, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) appl...
2024-07-01 10:56
1992
Comprehensively Covering Multiple Myeloma: IASO Bio's GPRC5D CAR-T Product RD118 Receives IND Approval from NMPA
NANJING, China, SHANGHAI and SAN JOSE, Calif., June 28, 2024 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies and antibody products, today announces thatthe investigational new d...
2024-06-28 18:59
2148
Hasten Announces Acquisition of 14 Celltrion Legacy Products, Accelerating its Business Expansion in the Pan-Asia Area
SHANGHAI, June 28, 2024 /PRNewswire/ -- Hasten Biopharmaceutical Co., Ltd. (referred to as "Hasten") announced today that it has successfully acquired the asset rights of 14 branded products across Pan-Asia countries and regions from Celltrion, a Korean biopharmaceutical company. According to the...
2024-06-28 16:26
7089
Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 28, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or " Sirnaomics"; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, toda...
2024-06-28 13:44
2408
Natalia Vodianova Invests in Swiss Beauty and Longevity Brand NIANCE
ZURICH, June 27, 2024 /PRNewswire/ -- Swiss Health & bioBeauty AG, owner of the prestigious beauty and longevity brand NIANCE, announces that internationally renowned supermodel, philanthropist, and investor Natalia Vodianova has become one of the key shareholders of NIANCE. This strategic partne...
2024-06-28 11:59
1572
Innovent Provides Interpretation and Updates on Clinical Data from Mazdutide GLORY-1 Study and General Biomedicine Pipeline
SAN FRANCISCO and SUZHOU, China, June 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...
2024-06-28 08:00
2511
Neogen® Launches Petrifilm® Automated Feeder to Improve Efficiency of High-Throughput Food Safety Testing
Petrifilm end-to-end solution reduces hands-on enumeration time from 4 hours to 1 minute LANSING, Mich., June 27, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, is helping high-volume food safety testing laboratories implement a more effic...
2024-06-27 20:45
4194
Top 5 Global Biotech Company Goes Live with LifeSphere® MultiVigilance and Reporting & Analytics Solution
* The top-tier life sciences company will standardize its Safety operations on the cloud-powered technology platform, LifeSphere, which is propelling life sciences GenAI use cases. * The company will use LifeSphere MultiVigilance and Reporting & Analytics Solution to process some600,000 adver...
2024-06-27 20:00
2033
US FDA New Drug Application Approval of Ohtuvayre™ (ensifentrine) for the Maintenance Treatment of COPD
SHANGHAI, June 27, 2024 /PRNewswire/ -- Nuance Pharma's global partner Verona Pharma plc (Nasdaq: VRNA), announces the US Food and Drug Administration ("FDA") approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. Ohtuvay...
2024-06-27 13:59
2151
HUADONG MEDICINE Announces Positive Phase I Results for Innovative Oral Small Molecule GLP-1 Receptor Agonist HDM1002
HANGZHOU, China, June 26, 2024 /PRNewswire/ -- HUADONG MEDICINE, through its wholly-owned subsidiary Hangzhou Zhongmei HuaDong Pharmaceutical CO. LTD (Zhongmei HuaDong), has recently announced positive results from Phase I clinical trials of its innovative oral small molecule GLP-1 receptor agoni...
2024-06-26 21:05
2491
TurtleTree Announces Strategic Partnership with Strive, a Sustainable Nutrition Company; Expands Consumer Product Offerings with LF+™ for Adult and Sports Nutrition
Strive and TurtleTree to Collaborate on a Immunity Support Beverage for Adults
and a Protein Powder to be Made Available to the Public Q1 2025
SACRAMENTO, Calif. and SINGAPORE, June 26, 2024 /PRNewswire/ -- TurtleTree
2024-06-26 21:01
3150
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5203
